Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
The New England Journal of Medicine|April 12, 2013
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Lauren S Maeda, et al.Nature|June 24, 2008
IRF4 addiction in multiple myelomaArthur L Shaffer, N C Tolga Emre, Laurence Lamy, et al.Cell|January 29, 2013
Identification of early replicating fragile sites that contribute to genome instabilityJacqueline H Barlow, Robert B Faryabi, Elsa Callén, et al.Blood|March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalRobin A Roberts, George Wright, Andreas R Rosenwald, et al.Nucleic Acids Research|June 26, 2010
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene functionDavid Warde-Farley, Sylva L Donaldson, Ovi Comes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissuesLisa M Rimsza, George Wright, Mark Schwartz, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 15, 2003
Distinguishing right from left colon by the pattern of gene expressionOleg K Glebov, Luz M Rodriguez, Kenneth Nakahara, et al.Cancer Cell|January 16, 2026
Axes of biological variation in diffuse large B cell lymphomaBoya Wang, George Wright, Julius C Enssle, et al.Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.Pageof 8